SEAT:NASDAQVivid Seats Inc. Analysis
Data as of 2026-09-01 - not real-time
$5.85
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Vivid Seats Inc. trades at $5.85, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Across the trailing 30 sessions it lost 16.4%. Momentum indicators put RSI at 34.8 (approaching oversold) with MACD reading bearish. The recent range runs from support at $5.81 up to resistance at $9.59.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 99.6% above the current quote. Revenue is contracting at 9.5% on a -60.3% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 99.4%, a beta of 1.55 and a maximum drawdown of 69.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 99.6% above the current quote. Revenue is contracting at 9.5% on a -60.3% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 99.4%, a beta of 1.55 and a maximum drawdown of 69.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.
Top Market Events
CHICAGO, July 21, 2026 GLOBE NEWSWIRE -- Vivid Seats Inc.Seeking Alpha27dVivid Seats Inc. SEAT Q2 2026 Earnings Call TranscriptGood morning, and welcome to Vivid Seats' Second...Seeking Alpha27dVivid Seats expects FY2026 marketplace GOV of $2.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 7.16
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 7.16
- Analyst targets imply +99.6% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -60.3%
- Analyst targets imply +99.6% versus the current price
- Negative return on equity of -396.0%
Key Metrics & Analysis
Financial Health
Revenue Growth-9.50%
Profit Margin-60.26%
P/E Ratio-1.5
ROE-395.99%
ROA-3.82%
P/B Ratio-0.6
Op. Cash Flow$7.5M
Free Cash Flow$21.2M
Industry P/E16.1
Technical Analysis
TrendBearish
RSI34.8
Support$5.81
Resistance$9.59
MA 20$6.99
MA 50$7.15
MA 200$7.16
MACDBearish
VolumeStable
Fear & Greed Index92.95
Valuation
Fair Value$0.46
Target Price$11.68
Upside/Downside99.63%
GradeFair
TypeBlend
Risk Assessment
Beta1.55
Volatility99.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.